A small-molecule allosteric inhibitor of BAX protects against doxorubicin-induced cardiomyopathy

Dulguun Amgalan(Albert Einstein College of Medicine), Richard N. Kitsis(Albert Einstein College of Medicine), Luis Rivera Sanchez(Albert Einstein College of Medicine), Rachel B. Hazan(New York University), Xiaotong F. Jia(Albert Einstein College of Medicine), Felix G. Liang(Albert Einstein College of Medicine), John S. Condeelis(Albert Einstein College of Medicine), Kelly Mitchell(Albert Einstein College of Medicine), Gaetano Santulli(Columbia University Irving Medical Center), Lorrie A. Kirshenbaum(St. Boniface Hospital), Evripidis Gavathiotis(Albert Einstein College of Medicine), Victoria Margulets(Technion – Israel Institute of Technology), Marco Scarlata(Albert Einstein College of Medicine), Randall T. Peterson(University of Utah), George S. Karagiannis(Albert Einstein College of Medicine), Andrea López(Albert Einstein College of Medicine), Ryan Pekson(Albert Einstein College of Medicine), Ulrich Steidl(Albert Einstein College of Medicine), Victor M. Paulino(Albert Einstein College of Medicine), Aarti Asnani, Swathi-Rao Narayanagari(Albert Einstein College of Medicine), Mounica Yanamandala(Brigham and Women's Hospital), Yun Chen(Nantong University), Jaehoon Lee(KT&G (South Korea)), Thomas P. Garner(Albert Einstein College of Medicine), J. Jose Corbalan(Research & Development Institute), Huizhi Liang(Albert Einstein College of Medicine), Maja H. Oktay(Albert Einstein College of Medicine)
Nature Cancer
March 2, 2020
Cited by 123


Related Papers